BioLife Solutions BLFS Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| —— | —— | -$68M+51.4% | -$139.81M-1,469% | ||
| $2.25M-56.3% | $5.16M-27.5% | $7.11M+5.0% | $6.78M+45.3% | ||
| $22.99M-25.6% | $30.92M-7.0% | $33.25M+31.2% | $25.33M+81.5% | ||
| $65K— | —— | -$62K+98.8% | -$5.24M+74.0% | ||
| -$264K-108% | $3.11M+120% | -$15.35M-243% | $10.75M— | ||
| —— | —— | —— | $6.56M+5,854% | ||
| —— | $26K— | —— | $414K-79.5% | ||
| —— | —— | —— | $1.79M+145% | ||
| $264K— | —— | —— | -$260K— | ||
| -$2.01M-107% | -$973K-173% | $1.33M— | —— | ||
| $20.12M+139% | $8.43M— | —— | —— | ||
| $9.56M+179% | $3.43M-46.2% | $6.38M-38.6% | $10.39M+23.9% | ||
| $114.06M+519% | $18.42M-32.0% | $27.1M— | —— | ||
| $6.83M+94.1% | $3.52M+1.4% | $3.47M+726% | $420K— | ||
| $23.52M-68.0% | $73.43M— | $0— | $0— | ||
| $0-100% | $300K— | $0— | $0— | ||
| -$72.68M-225% | $58.3M+227% | $17.84M+131% | -$58.12M-341% | ||
| $0— | $0-100% | $10.24M— | $0— | ||
| —— | —— | —— | —— | ||
| $33K— | —— | —— | -$3.39M-2,652% | ||
| -$10.92M-61.0% | -$6.78M-164% | $10.59M-37.5% | $16.94M+710% | ||
| -$65.91M-210% | $59.95M+276% | $15.93M+130% | -$53.31M-159% | ||
| $762K-52.6% | $1.61M-16.6% | $1.93M+229% | $586K+29.6% | ||
| $736K+55.3% | $474K-62.4% | $1.26M+182% | $447K— | ||
| $2.43M-30.5% | $3.5M— | —— | $9.7M— | ||
| -$510K+10.1% | -$567K+4.5% | -$594K+23.2% | -$773K-26.9% | ||
| $0— | $0-100% | $5.12M— | $0— | ||
| $10.32M-35.0% | $15.88M— | $0— | $0— | ||
| —— | —— | —— | $1.79M+145% | ||
| -$2.01M-107% | -$973K-173% | $1.33M— | —— | ||
| $3.04M+26.3% | $2.41M+1,857% | -$137K— | —— | ||
| $1.88M+342% | $424K+5.0% | $404K-88.4% | $3.49M— | ||
| —— | —— | —— | $3.77M+83.6% | ||
| $34.76M+88.9% | $18.4M-65.1% | $52.7M+520% | $8.5M— | ||
| $886K-57.2% | $2.07M-57.4% | $4.86M+35.8% | $3.58M-43.9% | ||
| $0-100% | $300K— | $0— | $0— | ||
| $6.83M+94.1% | $3.52M+1.4% | $3.47M+726% | $420K— | ||
| $33K— | —— | —— | -$337K— | ||
| $975K-59.3% | $2.4M+1.4% | $2.37M— | —— | ||
| $10M+100% | $5M+1,567% | $300K-82.0% | $1.67M— | ||
| $0— | —— | —— | —— | ||
| $108K— | —— | -$58K— | —— | ||
| $0— | $0-100% | $2.26M+177% | $817K— | ||
| —— | —— | -$20.21M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does BioLife Solutions generate?
- BioLife Solutions (BLFS) generated $17.9M in operating cash flow over the trailing twelve months.
- What is BioLife Solutions's free cash flow?
- After $9.6M of capital expenditures, BioLife Solutions's free cash flow was $14.1M over the trailing twelve months, up 110.7% year over year.
- Where does BioLife Solutions's cash flow data come from?
- Every line is extracted from BioLife Solutions's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
